Literature DB >> 12620651

Genetic polymorphisms of osteopontin in association with multiple sclerosis in Japanese patients.

Masaaki Niino1, Seiji Kikuchi, Toshiyuki Fukazawa, Ichiro Yabe, Kunio Tashiro.   

Abstract

Osteopontin (OPN) exhibits pleiotropic functions and abundant transcripts for OPN are present in brains of patients with multiple sclerosis (MS). The aim of this study was to investigate the role of OPN genes in the pathogenesis of MS. Polymorphisms at the 8090th, 9250th and 9583rd positions in OPN were detected by PCR-RFLP from DNAs of 116 MS Japanese patients and 124 healthy controls. The C/C genotype at the 8090th position in exon 6 was more prevalent in MS than in control (p<0.0001), and C allele was more prevalent in MS than in control (p<0.0001, OR=2.57, 95% CI=1.65-4.00). For the 9583rd position polymorphism in exon 7, patients with G/G genotype (age; 32.1+/-12.5 years, mean+/-S.D.) showed a later disease onset than G/A (age; 25.9+/-7.8 years, p=0.01) and A/A (age; 25.2+/-8.9 years, p=0.01) genotypes. There were no significant correlations between OPN gene polymorphisms and disease progression. Our results suggest that the 8090th polymorphism might be associated with susceptibility to MS, while the 9583rd polymorphism might be associated with age of onset of MS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12620651     DOI: 10.1016/s0165-5728(03)00004-3

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  15 in total

1.  Genetic Modifiers for Neuromuscular Diseases.

Authors:  Kay-Marie Lamar; Elizabeth M McNally
Journal:  J Neuromuscul Dis       Date:  2014

Review 2.  Neurogenetics II: complex disorders.

Authors:  A F Wright
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

Review 3.  A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3' UTR variants.

Authors:  Jian-Min Chen; Claude Férec; David N Cooper
Journal:  Hum Genet       Date:  2006-06-29       Impact factor: 4.132

4.  Transcriptome-wide discovery of microRNA binding sites in human brain.

Authors:  Ryan L Boudreau; Peng Jiang; Brian L Gilmore; Ryan M Spengler; Rebecca Tirabassi; Jay A Nelson; Christopher A Ross; Yi Xing; Beverly L Davidson
Journal:  Neuron       Date:  2014-01-02       Impact factor: 17.173

5.  Cleavage of osteopontin by matrix metalloproteinase-12 modulates experimental autoimmune encephalomyelitis disease in C57BL/6 mice.

Authors:  Angelika Goncalves DaSilva; Lucy Liaw; V Wee Yong
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

6.  Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets.

Authors:  Georgina Xanthou; Themis Alissafi; Maria Semitekolou; Davina C M Simoes; Erasmia Economidou; Mina Gaga; Bart N Lambrecht; Clare M Lloyd; Vily Panoutsakopoulou
Journal:  Nat Med       Date:  2007-04-15       Impact factor: 53.440

7.  Elevation of osteopontin levels in brain tumor cells reduces burden and promotes survival through the inhibition of cell dispersal.

Authors:  Stephen M Selkirk; Jay Morrow; Tara A Barone; Alan Hoffer; Jeffrey Lock; Anne DeChant; Saisho Mangla; Robert J Plunkett; Robert H Miller
Journal:  J Neurooncol       Date:  2007-10-11       Impact factor: 4.130

8.  A single-nucleotide polymorphism of the osteopontin gene may contribute to a susceptibility to Lewy body disease.

Authors:  Walter Maetzler; Joan Michelis; Juergen Tomiuk; Arthur Melms; Clemens Becker; Thomas Gasser; Claudia Schulte; Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2009-04-02       Impact factor: 3.575

9.  The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease.

Authors:  Jürgen Glas; Julia Seiderer; Corinna Bayrle; Martin Wetzke; Christoph Fries; Cornelia Tillack; Torsten Olszak; Florian Beigel; Christian Steib; Matthias Friedrich; Julia Diegelmann; Darina Czamara; Stephan Brand
Journal:  PLoS One       Date:  2011-12-29       Impact factor: 3.240

10.  Chemokine (C-C motif) ligand 20, a potential biomarker for Graves' disease, is regulated by osteopontin.

Authors:  Xiaoli Li; Yicheng Qi; Xinran Ma; Fengjiao Huang; Hua Guo; Xiaohua Jiang; Jie Hong; Dongping Lin; Bin Cui; Guang Ning; Lingyan Xu; Shu Wang
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.